| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.004 |